Myriad Genetics
Salt Lake City · Founded 1991
About Myriad Genetics
Myriad Genetics personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. Myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. Myriad is focused on three strategic imperatives: maintaining leadership in an expanding hereditary cancer market, diversifying its product portfolio through the introduction of new products and increasing the revenue contribution from international markets.
Company Facts
- Founded: 1991
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $500K – $1M
- Total funding: $215.0M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jul 2025)
- Ticker: nasdaq:MYGN
- Website: myriad.com
- Phone: (800) 469-7423
Industries & Categories
Biotechnology, Pharmaceutical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/myriad-genetics-25771 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.